Grace Therapeutics GRCE Cash Flow Statement (2018-2026)

NASDAQ GRCE
$2.26 +0.12 (+5.61%)
As of: Sep 10, 2026 · 12:34 PM EDT
Reported Financials

Grace Therapeutics Quarterly Cash Flow Statement

Periods 31 quarters
Latest Jun 2026

Grace Therapeutics reported cash from operations of -$3.22M and free cash flow of -$3.22M for the quarter ended Jun 2026, down 78.8% year over year. This cash flow statement covers 31 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
0.98M-3.78M-1.78M-4.52M-4.93M-3.89M-24.86M-4.02M-3.27M-2.39M-1.91M-2.62M-3.43M-4.16M0.64M-3.36M-0.94M-2.31M-0.89M-15.79M
Share-based Compensation
0.90M2.98M0.62M4.23M4.45M4.45M0.32M0.47M0.28M0.72M0.23M0.92M1.35M0.93M0.13M1.35M1.35M1.35M0.18M1.35M
Deferred Taxes
-0.21M2.58M-0.72M-0.85M-0.60M-1.02M-1.70M
Gains from Investment Securities
-3.44M-0.83M-0.29M-0.01M1.83M-0.12M1.03M-1.40M-0.36M1.18M-2.64M0.49M-1.43M0.04M
Asset Writedowns and Impairment
-0.25M0.41M13.53M
Non-cash Items
Cash from Operations
-6.10M-4.58M-3.15M-5.43M-3.44M-3.72M-3.33M-6.24M-2.11M-1.89M-2.09M-3.60M-4.24M-4.12M-2.95M-1.80M-3.14M-2.23M-1.70M-3.22M
Change in Working Capital
Change in Receivables
0.38M0.03M0.04M0.12M-0.24M-0.33M0.02M-0.11M-0.17M-0.11M
Change in Inventory
Change in Account Payables
-0.07M-1.45M-0.54M0.40M-0.06M0.91M0.08M-0.70M-0.37M0.71M-1.07M0.04M0.86M-0.90M
Change in Accured Expenses
-1.04M
Other Working Capital Changes
-0.01M-0.01M
Investing Activities
Capital Expenditures
0.01M0.00M0.01M0.02M
Sales of Property, Plant and Equipment
0.00M
Change in Acquisitions & Divestments
16.06M13.88M0.09M13.28M-0.10M5.00M6.57M
Cash from Investing Activities
2.84M0.56M0.01M13.26M-0.10M-5.00M4.99M0.11M-6.55M6.55M-0.01M0.01M
Financing Activities
Other financing activities
0.24M
Change in Capital Stock
Net Shares Issued and Repurchased
2.12M1.26M1.48M0.27M0.61M0.20M0.21M0.39M0.43M
Net Equity Issued and Repurchased
0.20M0.11M
Misc.
Cash from Financing Activities
0.20M0.11M7.36M14.03M-0.33M4.04M
Exchange Rate Effect
-0.98M-0.03M0.26M0.05M-0.22M0.30M-0.13M
Change in Cash
-4.05M-3.92M-2.67M8.04M-3.45M-8.69M1.63M-6.24M5.36M-8.45M4.46M-3.61M-4.24M-4.10M11.08M-2.13M-3.14M1.81M-1.70M-3.22M
Free Cash Flow
-6.10M-4.58M-3.15M-5.43M-3.44M-3.72M-3.33M-6.24M-2.11M-1.89M-2.11M-3.60M-4.24M-4.12M-2.95M-1.80M-3.14M-2.23M-1.70M-3.22M
Net Cash Flow
-3.27M-4.03M-3.13M8.03M-3.43M-8.72M1.67M-6.24M5.36M-8.45M4.46M-3.61M-4.24M-4.10M11.08M-2.13M-3.14M1.81M-1.70M-3.22M